Company / Cash per Share
Crinetics Pharmaceuticals, Inc. Cash per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.06
FY2025
5-year range
$0.61 / $4.22
FY2021-FY2025
Trend
-62.7%
vs FY2024
Sector context
#147 of 205
Health Care
What the data says
At $1.06, Crinetics Pharmaceuticals, Inc.'s cash per share ranks #147 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 9 years, ranging from $0.61 in FY2022 to $1869.12 in FY2019.
Based on SEC 10-K filings.
1.06 in FY2025 with a 5-year CAGR of -8.6%.
Improved from $0.95 to $1.06 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +20.6%
- 5-Year CAGR
- -8.6%
- 10-Year CAGR
- -
Sector benchmark
#147 of 205 in Health CareTop 72% of 205This company $1.06 Sector average $72.93
▼
-98.5% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 62.7% year-over-year.
- Ranks #147 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.06 | -62.7% |
| FY2024 | $2.85 | +201.1% |
| FY2023 | $0.95 | +55.9% |
| FY2022 | $0.61 | -85.6% |
| FY2021 | $4.22 | +153.7% |
| FY2020 | $1.66 | -99.9% |
| FY2019 | $1869.12 | +6340.2% |
| FY2018 | $29.02 | +180.4% |
| FY2017 | $10.35 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026